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Summary
 
The earliest lymphoid precursor population in the adult mouse thymus had previously been
shown to produce not only T cells, but also dendritic cell (DC) progeny on transfer to irradi-
ated recipients. In this study, culture of these isolated thymic precursors with a mixture of cy-
tokines induced them to proliferate and to differentiate to DC, but not to T lineage cells. At
least 70% of the individual precursors had the capacity to form DC. The resultant DC were as
effective as normal thymic DC in the functional test of T cell stimulation in mixed leukocyte
cultures. The cultured DC also expressed high levels of class I and class II major histocompati-
bility complex, together with CD11c, DEC-205, CD80, and CD86, markers characteristic of
mature DC in general. However, they did not express CD8
 
a
 
 or BP-1, markers characteristic
of normal thymic DC. The optimized mixture of five to seven cytokines required for DC de-
velopment from these thymic precursors did not include granulocyte/macrophage colony stim-
ulating factor (GM-CSF), usually required for DC development in culture. The addition of
anti–GM-CSF antibody or the use of precursors from GM-CSF–deficient mice did not pre-
vent DC development. Addition of GM-CSF was without effect on DC yield when interleu-
kin (IL) 3 and IL-7 were present, although some stimulation by GM-CSF was noted in their
absence. In contrast, DC development was enhanced by addition of the Flt3/Flk2 ligand, in
line with the effects of the administration of this cytokine in vivo. The results indicate that the
development of a particular lineage of DC, probably those of lymphoid precursor origin, may
be independent of the myeloid hormone GM-CSF.
 
D
 
endritic cells (DC)
 
1
 
 (1) are generally considered as rel-
atives of monocytes and macrophages and to be of
myeloid origin. Strong support for this view comes from
many studies on the outgrowth of DC in culture, induced
principally by GM-CSF, usually in association with other
cytokines including TNF-
 
a
 
 (2–11; for review see reference
12). The DC appear to derive from a progenitor also capa-
ble of forming granulocytes and macrophages (13), al-
though more recently a committed DC progenitor, possi-
bly a downstream precursor, has been identified (14). The
myeloid nature of DC is emphasized by the direct develop-
ment of a form of DC from blood monocytes (9, 15–17;
for review see reference 12). All these lines of evidence for
a myeloid origin of DC derive from culture studies using
GM-CSF.
In contrast to these studies, we have used adoptive trans-
fer of highly purified precursor cells isolated from the mouse
thymus to demonstrate that certain types of DC are related
to the lymphoid lineage. The earliest T precursor popula-
tion isolated from the adult mouse thymus, the “low CD4
precursor,” was unable to form detectable erythroid or my-
eloid cells, yet had the potential to form T cells, B cells,
NK cells, and DC (18–23; for review see reference 24). A
progenitor cell with similar developmental potential has
since been isolated from human bone marrow (25). T cells
and DC bearing CD8
 
a
 
, a characteristic of murine thymic
DC (26), developed in parallel when this low CD4 precur-
sor was transferred directly into a recipient thymus (21).
We have recently found that a downstream thymic precur-
sor (CD4
 
2
 
8
 
2
 
44
 
1
 
25
 
1
 
c-kit
 
1
 
), now no longer able to form B
cells or NK cells, still retains full capacity to form DC as
well as T cells, suggesting a strong relationship between the
two lineages (27).
 
1
 
Abbreviations used in this paper:
 
 CD40L, CD40 ligand; DC, dendritic cells;
Flt3L, Flt3/Flk2 ligand; SCF, stem cell factor.
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These thymic precursors also formed CD8
 
a
 
1
 
 DC in the
spleen after intravenous transfer, suggesting that the CD8
 
a
 
1
 
DC normally found in peripheral lymphoid tissues might
also be of lymphoid origin. These CD8
 
1
 
 splenic DC ap-
pear to have a regulatory role in T cell responses (28).
Our initial attempts to grow the thymic low CD4 pre-
cursors in culture under the influence of multiple combina-
tions of up to three cytokines were unsuccessful. Some
growth and development was obtained using an underlay
of a thymic epithelial cell line; under these conditions, a
limited production of DC was evident (29). However,
more extensive growth, with development into DC rather
than T cell progeny, was evident once a more complex
cocktail of cytokines was used. It was notable that GM-
CSF was not required for this DC development in culture.
 
Materials and Methods
 
Mice.
 
The mice used for isolation of thymic low CD4 pre-
cursors, or for isolation of thymic DC, were usually 5–7 wk-old
C57BL/6J Wehi females, bred under specific pathogen–free con-
ditions at The Walter and Eliza Hall Institute animal facility. The
GM-CSF–null mice, produced at the Ludwig Institute (30), were
originally on a C57BL/6 
 
3
 
 129 background but had been back-
crossed for five generations onto C57BL/6J mice; 5–9-wk-old
males and females were used. The source of the CD4
 
1
 
 LN T cells
for mixed leukocyte reactions was 5–6-wk-old female CBA/J
mice bred under specific pathogen–free conditions at The Walter
and Eliza Hall Institute.
 
Isolation of Normal DC from the Thymus.
 
The procedure was
modified from that given in detail elsewhere (26, 28, 31). Briefly,
pooled thymuses from 10 mice were cut into fragments, and the
entire tissue was digested for 25 min at 22
 
8
 
C with collagenase–
DNase. The digest was incubated a further 5 min with EDTA to
break up DC–T cell complexes. Light density cells were then iso-
lated from the digest by centrifugation at 4
 
8
 
C in a 1.077 
 
g
 
/cm
 
3
 
density medium isoosmotic with mouse serum. The light-density
cells were then coated with a cocktail of mAb reactive with CD3,
CD4, Thy 1, CD25, B cell antigen B220, erythrocyte antigen
TER119, granulocyte antigen Gr-1, macrophage antigen F480,
FcRII and CD11b, and then the coated cells were removed using
anti-Ig–coated magnetic beads. Finally the DC in the enriched
preparation were stained and sorted as cells excluding propidium
iodide, with the high forward and side scatter of DC, and ex-
pressing relatively high levels of CD11c (28).
 
Preparation of Low CD4 Thymic Precursor Cells.
 
An improved
procedure was used, modified from our original method (18) and
given in detail elsewhere (32). Briefly, the lightest 30% of thy-
mocytes were selected by a density cut procedure, and then all
adherent cells were removed by culture for 1 h in Petri dishes.
Cells bearing CD3, CD8, CD25, B220, class II MHC, Gr-1,
Mac-1, and the erythrocyte antigen TER 119 were all removed
by first coating with mAb, then removing coated cells with two
rounds of anti-Ig–coated magnetic beads. Finally, the 1% remain-
ing thymocytes were stained with anti-Thy 1 (PE-conjugated
30.H12) and anti–c-kit (FITC-conjugated ACK-2). The low
CD4 precursors were sorted as cells low but positive for Thy 1
and moderate to strongly positive for c-kit. The preparation was
 
.
 
97% pure on reanalysis by these markers and appeared homo-
genous by 14 other markers tested in previous experiments (18–21,
24, 32). In some experiments, the identical procedure was applied
to bone marrow cells, but the homogeneity of this preparation
was not assessed.
 
Culture Conditions.
 
The culture medium was based on RPMI
1640, modified to be isoosmotic with mouse serum (308 mosM),
with additional Hepes buffering at pH 7.2 and supplemented
with 10% FCS, 10
 
2
 
4
 
 M 2-ME, sodium pyruvate, and antibiotics.
The required cytokines were then added to the medium, and the
precursor cells were dispersed in the mix. Cultures were from 1 to
7 d at 37.5
 
8
 
C in a humidified 10% CO
 
2
 
-in-air incubator. For
most studies the culture volume was 0.01 ml, and culture of
1–3,000 cells was in the wells of Terasaki trays (Nunc, Naper-
ville, IL). When a larger cell yield was required for cell counts or
for surface phenotype analysis, 20,000 precursors were cultured in
0.1 ml medium in flat-bottomed 96-well culture trays (Disposable
Products Pty. Ltd., Adelaide, Australia).
 
Cytokines and Cytokine-related Antibodies.
 
The following con-
centrations of recombinant cytokines tested were used for culture
of the low CD4 precursors. IL-1
 
b
 
 (human), 200 U or 0.2 ng/ml;
TNF-
 
a
 
 (murine), 1 ng/ml; IL-3 (murine), 200 U or 400 ng/ml;
IL-4 (murine), 200 U or 20 ng/ml; IL-7 (human), 200 U or 10
ng/ml; GM-CSF (murine), 200 “Immunex units” or 200 ng/ml.
GM-CSF was found by titration at the end of the experimental
series to be 3,200 standard units or the equivalent of 16 ng/ml of
a standard Hall Institute preparation. These cytokines were all
provided by Immunex Corp. Flt3/Flk2 ligand (Flt3L), 100 ng/ml,
and antibody against GM-CSF, 2 
 
m
 
g/ml, was provided by Dr. N.
Nicola (The Walter and Eliza Hall Institute). CD40 ligand
(CD40L) and mAb against CD40, FGK45.5, 1 
 
m
 
g/ml, was pro-
vided by Dr. A. Rolink (Basel Institute for Immunology, Basel,
Switzerland).
 
Cluster Counts, Cell Counts, and Visualization of Dendritic Mor-
phology.
 
The incidence of DC clusters was counted directly on
the Terasaki tray cultures, using inverted phase–contrast micros-
copy; a group of 
 
.
 
20 cells was considered a cluster. To recover
and count cells after culture, one tenth volume of 0.1 M EDTA,
pH 7.2, was first added to the warm cultures, and then the cul-
tures were mixed by repeated passage through a pipette tip in or-
der to break up the DC clusters into a single cell suspension; cell
counts were then carried out in a hemocytometer using phase–
contrast microscopy. To assess dendritic morphology, a cell sus-
pension was prepared from pooled cultures using EDTA to aid
dissociation, as above. The cells were then washed by centrifuga-
tion through a layer of FCS and resuspended in a small volume of
culture medium. The suspension was placed in slide chambers,
prepared by fastening square coverslips onto microscope slides by
double-sided adhesive tape at two opposite edges. After filling the
chambers, the remaining edges were sealed with nail polish. The
slides were then incubated at 37
 
8
 
C for 1–2 h and then examined
under phase–contrast microscopy. To monitor the fate of individ-
ual precursor cells, Terasaki tray cultures containing only a single
precursor were selected after 2 h of incubation of cultures set up
using 1 cell/0.01 ml medium, and then the culture was inspected
every 24 h using inverted phase–contrast microscopy.
 
Immunofluorescent Staining and Flow Cytometry.
 
The procedures
used for staining the cultured DC were similar to those used pre-
viously for DC extracted from tissues (26). Two- or three-fluo-
rescent-color staining was used, propidium iodide was used to ex-
clude dead cells, and the samples were analyzed using a FACStar
Plus
 
Ò
 
 (Becton Dickinson & Co., San Jose, CA). The mAbs and
the fluorochromes used were as follows: CD4, Cy5-conjugated
H129.19.6.8; CD8
 
a
 
, biotin-conjugated 53-6.7; CD8
 
b
 
, biotin-
conjugated 53-5.8; CD3, PE-conjugated KT3-1.1; class I MHC,
biotin-conjugated M1/42; class II MHC, Texas red–conjugated 
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N22; CD11c, biotin-conjugated N418; DEC205, FITC-conju-
gated NLDC145; BP-1, biotin-conjugated 6C3; CD11b, FITC-
conjugated M1/70; F480 macrophage antigen, biotin-conjugated
F4/80; B220, biotin-conjugated RA3-6B2; CD80 (B7/1), biotin-
conjugated 16-10A1; CD86(B7/2), biotin-conjugated GL-1; CD40,
FITC-conjugated FGK45.5; CD44, FITC-conjugated IM7.81;
Gr-1, FITC-conjugated RB6-8C5; and CD25, biotin-conju-
gated PC61. PE-conjugated streptavidin was used as the second
stage for all biotin conjugates.
 
Mixed Leukocyte Cultures for Assessing CD4 T Cell Stimulatory
Capacity.
 
The cultures were set up and T cell proliferation was
determined as described previously (28). Briefly, 100–2,000 DC
of C57BL/6 origin, either harvested from the cultures or isolated
from the thymus, were cultured with 20,000 purified CD4 T cells
isolated from the LN of CBA mice. The culture medium was
modified RPMI 1640, 0.1 ml being used in the wells of V-bot-
tom 96-well culture trays. No exogenous cytokines were added.
After 2–4 d at 37.5
 
8
 
C in a 10% CO
 
2
 
-in-air incubator, the cultures
were pulsed for 9 h with [
 
3
 
H]TdR. Cells in the cultures were
harvested onto glass-fiber filters, and incorporated radioactivity
was measured in a gas-flow scintillation counter.
 
Results
 
Culture of Low CD4 Precursors with One to Three Cyto-
kines.
 
In our initial studies, the low CD4 precursors were
isolated from adult mouse thymus by depletion and sorting,
and then they were cultured at 50–1,000 cells per well in
Terasaki tray cultures with a range of recombinant cyto-
kines. The cytokines were tested singly or in combinations
of two or three. In no case of cytokines used alone or in
combinations of up to three was any growth detected. This
included the cytokines normally used to produce DC in
culture, namely, GM-CSF or GM-CSF in combination
with TNF-
 
a
 
 and/or IL-4. It also included IL-2 and IL-6,
not used in our subsequent studies.
However, almost all the cytokines, even when used sin-
gly, gave some improvement in low CD4 precursor sur-
vival. After 36 h of culture in medium alone, an average of
only 10% of the precursors were viable. The cytokines,
which, when used alone, increased survival to 
 
.
 
30%, were
IL-3, IL-6, stem cell factor (SCF), TNF-
 
a
 
, IL-4, and GM-
CSF; IL-7 gave the best survival, 55%. No combination of
cytokines gave a survival 
 
.
 
45%. Some combinations of cy-
tokines reduced survival to that of the medium alone, in
particular, TNF-
 
a
 
 with GM-CSF, TNF-
 
a
 
 with SCF,
TNF-
 
a
 
 with IL-4, and IL-4 with IL-7. This indicates that
low CD4 precursors expressed receptors for many of these
cytokines but that the interactions between them were
complex.
 
Growth and Differentiation of Low CD4 Precursors in Response
to Multiple Cytokines.
 
In contrast to this lack of proliferation
in response to combinations of up to three cytokines, some
growth and differentiation of the low CD4 precursors was
obtained on thymic epithelial cell lines (29). This encour-
aged us to test a complex cocktail of seven cytokines, in-
cluding some that might have been produced by thymic
epithelial cells, namely, TNF-
 
a
 
, IL-1
 
b
 
, IL-3, IL-4, IL-7,
SCF, and GM-CSF. This cytokine cocktail was tested on
the purified precursors cultured alone, without the thymic
epithelial cell underlay. It produced a definite growth of
precursors, doubling the input cell number by day 3. A re-
quirement for multiple cytokines to induce growth in the
low CD4 precursors has also been reported by Moore and
Zlotnik (23). However, in our cultures the end-product
cells appeared to be DC. Cells with cytoplasmic extensions
and DC morphology appeared by day 1. From day 2 to day
4 of culture, a high proportion of the cells formed large
clusters of 
 
z
 
50 cells, resembling closely the DC clusters
generated by culturing bone marrow or blood precursors
with GM-CSF and other cytokines (2–9). The majority of
cells in the cultures had the morphological appearance of
DC by day 4.
The clusters appeared to form as a result of aggregation,
rather than representing true colonies derived from single
precursors. Nevertheless, over the range of 100–5,000 low
CD4 precursor cell input, there was a dose–response rela-
tionship between cells cultured and clusters formed at day 4,
with five to eight clusters being formed per 1,000 cells cul-
tured (Fig. 1). Accordingly, scoring the number of large
clusters formed in the Terasaki well cultures provided a
rapid assay for proliferation and DC production. With rela-
tively dense cultures (3,000 precursors per well) a statisti-
cally reliable estimate could be made with around five cul-
tures per point. Such a cluster count was used as the initial
readout for screening the contribution of different cyto-
kines.
 
The Effect of Omitting Cytokines on DC Cluster Develop-
ment.
 
To determine which of the cytokines in the com-
plex mix were essential, the effect of leaving out one or
two individual cytokines from the initial mix was systemat-
ically assessed, using the incidence of DC clusters at day 4
as a readout (Fig. 2). Several cytokines (GM-CSF, IL-4, IL-7,
Figure 1. The relationship between the number of low CD4 precur-
sors cultured and the number of DC clusters produced. Purified thymic
low CD4 precursors were cultured for 4 d in 0.01 ml medium in Terasaki
tray cultures. The number of clusters (.20 cells) per well was counted
under phase–contrast microscopy. The initial complement of seven cy-
tokines was used (TNF-a, IL-1b, IL-3, IL-4, IL-7, SCF, and GM-CSF).
The results are the means 6 SEM of pooled data from three experiments,
each with five cultures per point. 
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SCF, and IL-3) could be omitted individually without much
effect on cluster formation. However, their absence gener-
ally did have an effect if omitted along with another cyto-
kine; one exception was the omission of GM-CSF and IL-4
together, where no drop was evident. The two cytokines
whose omission, either alone or in combination with other
cytokines, had the greatest effect were IL-1
 
b
 
 and TNF-
 
a
 
.
When omitted together, cluster formation dropped to 8%
of that seen with the complete mix. It was also notable that
when GM-CSF was omitted, cluster formation became
very dependent on IL-7. In contrast, the omission of both
GM-CSF and IL-3, which share a common receptor chain
(33) and might therefore have substituted for one another,
caused only a small drop in cluster formation.
Accordingly, IL-1
 
b
 
 and TNF-
 
a
 
 were considered essen-
tial components of the mix, whereas GM-CSF and possibly
IL-4 appeared dispensable. To check this further, GM-CSF
was omitted from the mix, and the effects of omitting one
or two further cytokines (except IL-1
 
b
 
 and TNF-
 
a
 
) was
examined (Fig. 3). As predicted from Fig. 2, the further
omission of IL-4 had no effect on cluster formation. IL-4
was omitted from subsequent cytokine cocktails. Fig. 3 con-
firms the data of Fig. 2 showing that the omission of IL-7
in the absence of GM-CSF now had a marked effect on
cluster formation, although interestingly this drop was less
when other cytokines, in particular IL- 4, were absent. Of
the remaining cytokines, IL-3 appeared in these experi-
ments to have the least influence, but it was retained in
subsequent studies to maintain maximal DC cluster forma-
tion.
 
Effect of Antibody Against GM-CSF on Development of DC
Clusters.
 
The lack of any requirement for GM-CSF in the
production of DC was surprising, in view of its require-
ment for DC outgrowth in other systems. It was possible
the low CD4 precursors themselves, or some trace contam-
inant, produced sufficient endogenous GM-CSF. To test
this possibility, a neutralizing antibody against GM-CSF
was added to the cultures when they were initiated at a
level known to block GM-CSF–dependent colony forma-
tion in culture. The cultures were stimulated by the above
“optimal” mix of five cytokines, lacking GM-CSF. How-
ever, there was no significant drop in the number of DC
clusters formed, nor any reduction in the apparent size of
the clusters, when the antibody was added (Table 1). In
view of the possibility that IL-3 was substituting for GM-
CSF, because they share a common receptor chain (33),
the test was repeated with both IL-3 and GM-CSF omitted
from the cytokine mix. Again, the anti–GM-CSF had no
significant effect in these relatively high density cultures.
 
Cytokine Requirements in Low Cell Density Cultures.
 
Finally,
to verify the requirement for all five cytokines, some simpler
combinations were tested, at a lower precursor cell input
Figure 2. The effect of omitting one or two cytokines from the initial
mix of seven on the formation of DC clusters. All results are expressed as
a percentage of the number of clusters formed with the complete control
cytokine mix. The values given along the diagonal, outlined by the
heavier boxes, represent single-cytokine omissions. Other boxes give re-
sults for two cytokine omissions. Thymic low CD4 precursor cells were
cultured at 3,000 cells per well in Terasaki culture plates, and the number
of clusters of DC were counted at day 4. The results are means 6 SEM of
pooled data from three to five experiments with five cultures per condi-
tion per experiment.
 
Table 1.
 
The Effects of Antibody Against GM-CSF on the 
Generation of DC Clusters by Cultured Thymic Low CD4 Precursors
 
Cytokine mix
Anti–
GM-CSF
Clusters
per well
TNF-
 
a
 
 
 
1 
 
IL-1 
 
b
 
 
 
1
 
 IL-7 
 
1
 
 SCF 
 
1
 
 IL-3
 
2
 
20 
 
6
 
 2
 
1
 
18 
 
6
 
 2
TNF-
 
a
 
 
 
1 
 
IL-1 
 
b
 
 
 
1
 
 IL-7 
 
1
 
 SCF
 
2
 
22 
 
6
 
 2
 
1
 
19 
 
6
 
 1
Purified thymic low CD4 precursors were cultured at 3,000 cells per
well in 0.01 ml medium for 4 d with the cytokines listed. Full details are
given in Materials and Methods. Results are the means 
 
6
 
 SEM of
pooled data from three experiments, each with five cultures per assay.
Figure 3. The effects of omitting one or two cytokines from an initial
mix of six on the formation of DC clusters. The experiment was similar
to that described in Fig. 1, except that GM-CSF was not included in the
initial mix, and that both IL-1b and TNF-a were maintained as constant
components.2189 Saunders et al.
(250 precursors per culture) to reduce any effects of endog-
enous growth factor production. All simpler cytokine com-
binations gave fewer DC clusters, or no clusters at all (Ta-
ble 2), and the few clusters that were obtained appeared
smaller. Two aspects of these low cell density cultures were
notable. First, neither DC cluster formation nor cell expan-
sion was evident in cultures with IL-1b alone or TNF-a
alone, or IL-1b plus TNF-a, even though these cytokines
were essential for the growth of DC in the cytokine mix.
However, in the cultures with IL-1b alone, or in cultures
with IL-1b plus TNF-a, z20% of the individual, nonclus-
tered surviving cells acquired dendritic morphology, sug-
gesting IL-1b alone promoted some direct DC differentia-
tion without cell division. In accordance with this, a few
DC clusters were obtained when very high density cultures
were incubated in IL-1b plus TNF-a (data not shown). A
second aspect of the sparse cultures was the degree of de-
pendence on IL-3 for DC cluster formation. In contrast to
the dense cultures where omission of IL-3 had a smaller
and variable effect (Figs. 2 and 3; Table 1), omission of IL-3
from the sparse cultures caused a much greater drop in both
DC cluster formation and cell proliferation. A low level of
endogenous IL-3 production by the precursor cells them-
selves is one possible explanation for this difference.
Under these low cell density culture conditions with the
five cytokine mix, a net increase of the cells in the cultures
was obtained, with growth extending longer and reaching
three to four times the original cell input (Fig. 4). Over
90% of the cells harvested at days 3 to 4 of culture had den-
dritic morphology.
The Effect of CD40 Ligation and Flt3 Ligand Addition on
DC Development. While our studies were in progress, two
further stimuli of DC development were reported. Soluble
CD40L has been found to enhance DC survival and differ-
entiation (34; for review see reference 12). Although it was
ineffective alone, we found it enhanced the DC develop-
ment stimulated by our previous five-cytokine mix. In the
presence of soluble CD40L, the cultured cells more rapidly
attained the extreme DC form with extended dendrites,
the number of clusters and their size was increased, the cell
yield increased, and fewer cells were found outside the
clusters. The impression was of enhanced differentiation
with an earlier peak of DC production. Very similar results,
but more reproducible in the extent of the effect, were ob-
tained by adding the mAb FGK45.5, reactive with CD40.
This mAb was used instead of soluble CD40L in the exper-
iment shown in Fig. 5 and subsequent experiments.
Recent studies at Immunex (35) have demonstrated that
Flt3L injected into mice induces a striking increase in the
levels of all types of DC in mouse lymphoid organs. Al-
though Flt3L was without effect on the low CD4 precur-
sors alone, when added together with the previous five-
cytokine mix it enhanced DC development in culture. The
number of cells produced in the cultures increased substan-
tially and peaked earlier, whereas the clusters increased a
little in both number and size (Fig. 5). The progeny cells
again had DC morphology, although of a less extreme form
than with CD40L.
The addition of both Flt3L and the mAb ligating CD40
to the cytokine mix of TNF-a, IL-1b, IL-3, IL-7, and
SCF appeared to produce the optimal yield and morpho-
logical form of DC from the cultured low CD4 precursors,
although these two additional “cytokines” were ineffective
if used alone. With this new seven-“cytokine” mix, the
numbers of cells produced from the thymic precursors
Table 2. The Effects of Various Cytokine Combinations on the 
Generation of DC Clusters in Low-Density Cultures of
Thymic Precursors
Cytokines Clusters per culture
No cytokines 0 6 0
IL-1b 0 6 0
TNF-a 0 6 0
TNF-a 1 IL-1b 0 6 0
IL-1b 1 TNF-a 1 SCF 0 6 0
IL-1b 1 TNF-a 1 IL-3 0.4 6 0.6
IL-1b 1 TNF-a 1 IL-7 0.1 6 0.2
IL-1b 1 TNF-a 1 IL-7 1 SCF 0.1 6 0.2
IL-1b 1 TNF-a 1 IL-7 1 IL-3 0.2 6 0.4
IL-1b 1 TNF-a 1 SCF 1 IL-3 0.4 6 0.6
IL-7 1 SCF 1 IL-3 0.1 6 0.1
IL-1b 1 TNF-a 1 IL-7 1 SCF 1 IL-3 2.0 6 0.9
Cultures of 250 low CD4 precursors were set up on 0.01 ml medium
in Terasaki tray wells. The incidence of DC clusters was determined af-
ter 4 d of culture. Results are the means 6 SEM of data pooled from
two experiments, each with 20 cultures per condition.
Figure 4. The growth of purified thymic low CD4 precursors under
the influence of a mixture of five cytokines. Full details are given in Ma-
terials and Methods. The mix of five cytokines used was IL-1b, TNFa,
IL-3, IL-7, and SCF, omitting the IL-4 and GM-CSF used in the original
mix. The precursors (250) were cultured in 0.01 ml medium in Terasaki
tray wells. Cell counts were performed after harvest in a hemocytometer
with viability assessed by appearance under phase–contrast microscopy.
Values are means 6 SEM of pooled data from three experiments, each
with 20 cultures per point.2190 Dendritic Cell Development in Culture
reached four- to fivefold the initial input by day 4 of cul-
ture (Fig. 5); this was a minimal estimate, because under
these conditions the clusters were difficult to completely
dissociate even with EDTA. The number of clusters was
also maximized, and peaked at day 4, with this mix (Fig. 5).
The appearance of the clusters is shown in Fig. 6. Over
95% of the individual cells harvested and recovered from
such cultures had the morphological appearance of DC, all
having multiple fine cytoplasmic extensions and many hav-
ing more obvious “dendrites,” as illustrated in Fig. 6.
To provide a comparison with the thymic precursors, a
population of bone marrow precursors was also cultured
with this seven-“cytokine” mix. The bone marrow precur-
sors were selected by the same procedure used for the thy-
mic precursors to produce a c-kit1Thy-1low lineage marker–
negative, light density, nonadherent population; however,
there was no evidence that this was a homogenous precur-
sor population. Growth from this bone marrow population
was rapid and extensive, reaching 10 times the initial cell
input number by day 4. The resultant cell population was
of mixed phenotype and included myeloid cells and early B
cells. DC and DC clusters were produced, but comprised
only 24% of the total cell yield; the net DC production was
about half that obtained from the thymic precursors.
Production of DC in Culture by Thymic Low CD4 Precursors
from GM-CSF Null Mice. The surprising lack of any re-
quirement for GM-CSF in DC generation required a more
critical assessment. It was possible that traces of endoge-
nously derived GM-CSF persisted in the cultures despite
the antibody-blocking experiments of Table 1. It was also
possible that GM-CSF was required for the generation of
the precursors from multipotent stem cells rather than at
the later DC developmental steps reflected in our cultures.
Accordingly, we assessed the development in culture of the
thymic low CD4 precursors derived from GM-CSF “null”
mice, with the GM-CSF gene deleted by homologous re-
combination (30). The yield of low CD4 precursors from
the thymus of the GM-CSF “null” mice was similar to that
obtained from the normal C57BL/6 control mice, indicat-
ing that the generation of this precursor population was in-
dependent of GM-CSF. When cultured at low cell density
with the final complement of seven “cytokines” as in Fig. 5
(lacking GM-CSF), the thymic precursors from the GM-
CSF null mice showed extensive proliferation and pro-
duced DC clusters, with .90% of the product cells show-
ing typical dendritic morphology (Table 3). However, both
the total cell expansion and the number of DC clusters was
only 70–75% that obtained by culturing the same number
of low CD4 precursors from normal mice. Thus, although DC
development occurred efficiently in the absence of GM-CSF,
it remained possible that traces of endogenous GM-CSF could
enhance this development. Alternatively, GM-CSF in the
normal mice may have slightly “conditioned” the precur-
sors for an enhanced response, or removed some irrelevant
cells from the “low CD4 precursor” pool.
Effects of IL-3 and GM-CSF on DC Development in Low
Cell Density Cultures. The results with the GM-CSF null
mice suggested that GM-CSF might have some stimulatory
effect in low-density cultures, despite its lack of effect in
the earlier high precursor cell input studies. Another possi-
bility was that the requirement for GM-CSF was being
largely met by the added IL-3, via interaction with a com-
mon receptor b chain; because the requirement for IL-3
only became pronounced in low-density cultures (Table 2),
it was important to recheck this issue under these condi-
tions. Accordingly, low CD4 precursors were cultured
with IL-1b, TNF-a, IL-7, SCF, Flt3L, and anti-CD40
mAb, and then the effects of adding IL-3 and/or GM-CSF
were examined (Table 4).
Precursor cell expansion and DC development occurred
in the absence of both IL-3 and GM-CSF, with the vast
majority of cultured cells having dendritic morphology and
aggregating into clusters. However, the yield of both DC
and DC clusters was about half that seen in the presence of
IL-3. Therefore, GM-CSF could partially substitute for IL-3
under these conditions. However, GM-CSF did not syner-
Figure 5. The effect of addition of Flt3L and mAb against CD40 on
the growth and development of DC clusters from thymic low CD4 pre-
cursors. Cultures of 250 purified low CD4 precursors were set up in 0.01 ml
medium in Terasaki tray culture wells. The finer continuous line gives the
results with the basic cytokine mix (TNF-a, IL-1b, IL-3, IL-7, SCF [d]).
The two broken lines give the results of addition of Flt3L (s) or of the
mAb FGK45.5 reactive with CD40 (h). The heavy line gives the results
of adding both these reagents (D). Results are the means of pooled data
from three to four experiments, each with 20 cultures per point. For clar-
ity, SEM are only given for one set of data; the errors were similar in the
other sets. Statistically significant increases over the results obtained with
the basic five cytokine mix were obtained at day 4 of culture by adding
Flt3L (cells, P ,0.001), by adding anti-CD40 (cells, P ,0.001; clusters,
P 5 0.01–0.001) and by adding both anti-CD40 and Flt3L (cells, P ,0.001;
clusters, P ,0.001).2191 Saunders et al.
gize with IL-3, because some inhibition in cell expansion
was noted when both were added together. Similar but
slightly reduced effects were obtained when GM-CSF was
added to the cultures at a 10-fold lower concentration.
The Surface Phenotype of the Cultured DC. Immunofluo-
rescent staining and flow cytometry was used to analyze the
surface antigens on the cultured cells. Figs. 7 and 8 give re-
sults for day 4 cultures of low CD4 precursors grown in the
mix of TNF-a, IL-1a, IL-3, IL-7, and SCF, together with
the results for cultures grown in these five cytokines to-
gether with Flt3L and the anti-CD40 mAb. The surface
phenotype of the DC was similar under these two condi-
tions. It was also largely unchanged when day 6 cultures
were compared with day 4 cultures.
Of the characteristic T cell markers, the cells from these
cultures lacked CD4, CD8a, CD8b (not shown), CD3,
and CD25. This implied they had lost the low level of
CD4 characteristic of the precursors, but had not pro-
gressed to the next downstream CD251 precursor, nor had
they formed mature T cells. Surprisingly, they had not
gained CD8a, a marker characteristic of most thymic DC.
The cells were Thy 1 positive, showing a wide range of
Thy 1 expression; however, because many types of cul-
tured cells express Thy 1, this marker is not useful for de-
fining T lineage cells in culture.
Of the B lymphocyte lineage markers, the cells lacked B220,
and also lacked BP-1, an early B cell marker expressed on
thymic DC. However, BP-1 is known to be induced on DC
by the thymic environment, and the low CD4 precursors
produce BP-12 DC if allowed to develop in the spleen (27).
Figure 6. The clusters of DC
and the individual DC develop-
ing in culture from thymic low
CD4 precursors. The purified
low CD4 precursors were cul-
tured for 4 d in the presence of
TNF-a, IL-1b, IL-3, IL-7, SCF,
Flt3L, and FGK45.5, the mAb
reactive with CD40. The clusters
(A) were photographed directly
in the Terasaki tray cultures. The
individual DC (B and C) were
dissociated from the clusters us-
ing EDTA, replaced in culture
medium in a slide chamber, and
warmed for 2 h before photogra-
phy. Almost all cells had multiple
fine hairlike cytoplasmic exten-
sions, only some of which are
visible in the photographs. Orig-
inal magnifications: (A) 3260;
(B and C) 3640.
Table 3. The Growth and Development of DC Clusters from 
Thymic Low CD4 Precursors from GM-CSF “Null” Mice
Control C57BL/6
precursors
GM-CSF null
precursors
Cells per culture 1,002 6 109 721 6 69
Clusters per culture 5.7 6 1.6 4.7 6 1.6
Purified low CD4 precursors, 250 per 0.01 ml medium in Terasaki cul-
ture wells, were cultured for 4 d in the presence of TNF-a, IL-1b, IL-3,
Il-7, SCF, Flt3L, and FGK45.5 mAb against CD40. Results are the
means 6 SEM of pooled data from two experiments, each with 20 cul-
tures per determination.2192 Dendritic Cell Development in Culture
Of the macrophage/granulocyte markers, the cells were
negative for Gr-1. They stained at levels varying from neg-
ative to moderately positive for CD11b (Mac-1) and nega-
tive to moderately positive for F4/80. The very strong
staining characteristic of macrophages was not seen with
either marker. CD11b is expressed at levels ranging from
low to high on different lymphoid tissue DC (26, 27, 35).
F4/80 has been observed on cultured DC precursors (13),
but is not normally expressed at this level on mature tissue
DC (26).
Of the typical DC markers, the cultured cells expressed
very high levels of class I and class II MHC, high levels of
CD11c, and moderate levels of DEC205. They expressed
B7-1 (CD80) and B7-2 (CD86), characteristics of mature
DC. As do most DC, they expressed CD40, CD44, and
HSA, the heat stable antigen (not shown); these markers
are also found on other cell types. They also had the high
forward and side scatter characteristic of DC, as expected
from their size and appearance in Fig. 6. Overall they re-
sembled mature DC, the only anomaly being the absence
of CD8a, a marker characteristic of thymic DC in the
mouse but present on only about half of splenic or LN DC.
It should be noted that the low CD4 precursors lack surface
class II MHC, CD11c, DEC205, CD80, and CD86 (20,
21, 29), an observation we confirmed in this study (data
not shown), so differentiation toward expression of these
DC markers had occurred in the cultures.
T Cell Stimulatory Activity of the Cultured DC.  To de-
termine if the culture system produced functional DC, the
DC produced from thymic precursors by culture in the
presence of IL-1b, TNF-a, IL-3, IL-7, SCF, Flt3L, and
mAb binding CD40 were compared with freshly isolated
thymic DC in their ability to stimulate the proliferation of
allogeneic CD4 T cells. The small scale mixed leukocyte
cultures used (28) involved 20,000 pure CD41 LN T cells
as responders, and small numbers of either pure thymic DC
or cultured DC as stimulators; no exogenous cytokines
were added. Both the DC cultured with the full seven-
cytokine mix and the normal thymic DC were found to be
efficient stimulators of mature T cell proliferation; both
gave a proliferative response peaking at day 3 to 3.5, and
both gave a good DC dose–response relationship and a
very high stimulation index (Fig. 9). The DC cultured with
the full cytokine mix generally gave better T cell stimula-
tion than freshly isolated thymic DC.
Frequency of Responding and DC-producing Precursors.
The rapid increase in cell counts during the response of the
low CD4 precursor preparation to the cytokine mixes (Figs.
4 and 5) suggested that a significant proportion of the cells
were responding. However, because it required z50 pre-
cursors to form one DC cluster at day 4, it may have been
that only 2% of the precursor population was committed to
DC development. The argument against this was that the
incidence of cells with DC morphology was very much
higher than 2% early in the culture, and that the clusters
represented aggregates rather than colonies derived from a
single precursor. To determine the actual incidence of re-
sponding cells, a series of experiments was conducted in
which the low CD4 precursors were set up in Terasaki tray
cultures at the 1-cell-per-well level in medium containing
the optimum mix of “cytokines” (IL-1b, TNF-a, IL-3,
IL-7, SCF, Flt3L, and anti-CD40). After 2 h, the cultures
were examined under inverted phase microscopy, and cul-
tures with a single precursor in the well were selected for
further day-by-day observation. In one such experiment
the fate of 27 single precursor cells was followed over 3 d.
By day 1, nine of the starting cells had died, but all but one
of the remaining viable cells showed a clear DC morphol-
ogy; of these 70% survivors with DC morphology, 20%
had already undergone one cell division. By day 3, one fur-
ther culture had terminated in cell death, but all the re-
mainder had divided to produce between 2 and 10 prog-
eny; 90% of the viable progeny cells in these clones were of
DC morphology. In some cases, the progeny cells stayed
associated as a minicluster, but in many cultures they moved
apart. Two subsequent experiments confirmed these obser-
vations. Thus the majority (at least 70%) of the cells in the
low CD4 precursor preparation could be considered as po-
tential DC precursors. We are unable to assess whether the
30% of precursors that died in our cultures were also po-
tential DC precursors, or whether these cells were commit-
ted to another lineage. It was of interest that differentiation
of these low CD4 precursors to a DC morphology was
rapid and usually preceded cell division.
Table 4. The Influence of GM-CSF and IL-3 on DC Development from Low CD4 Thymic Precursors in Low-Density Cultures
Cytokines
Day 4
Cells per culture Clusters per culture
IL-1b, TNF-a, IL-7, SCF, Flt3L, anti-CD40 alone 4,930 1.8 6 0.4
IL-1b, TNF-a, IL-7, SCF, Flt3L, anti-CD40 plus IL-3 10,130 4.3 6 0.4
IL-1b, TNF-a, IL-7, SCF, Flt3L, anti-CD40 plus GM-CSF 6,570 3.7 6 0.4
IL-1b, TNF-a, IL-7, SCF, Flt3L, anti-CD40 plus IL-3 and GM-CSF 8,360 4.6 6 0.5
Purified low CD4 thymic precursors were cultured at 250 cells per well in 0.01 ml medium for 4 d with the cytokines listed. Results are the pooled
data from two experiments, each with 20 cultures per condition. Cluster counts are the means 6 SEM of individual direct culture counts. Cell
counts were performed on the pool of the 20 cultures in each experiment after harvest, and the results are the mean of the two experiments.2193 Saunders et al.
Discussion
The growth in culture of a highly purified early thymic
T precursor population, the low CD4 precursor, has led
in these experiments to the development of DC rather than
T cells. Because on intravenous transfer to irradiated recip-
ients this same population forms T cells, B cells, NK cells,
and DC (18–23; for review see reference 24), only one of
these potentials has been realized under our culture condi-
tions. We cannot at present determine whether all the
cells in this precursor population have all four developmen-
tal potentials, because we are at present unable to produce
T cells, B cells or NK cells from these precursors in culture.
However, because at least 70% of these cells, originally se-
lected as being precursors of T cells, have the potential to
develop into DC, we consider it likely that the T lympho-
cyte precursors and the DC precursors are identical. It
seems highly unlikely that the DC arise from a 70% mye-
loid precursor “contaminant” in the T precursor popula-
tion because there was no detectable myeloid response in
transfer experiments (19), and the incidence of cells able to
respond to GM-CSF by forming colonies or proliferating
in culture is <1% (19, 29). The results support the view
that thymic DC are of lymphoid precursor origin.
The cytokine mix we have used to produce DC is totally
different from those usually used to produce DC in culture,
and it is much more complex. Some of this complexity
may be attributed to our use of a pure precursor popula-
tion, because there are no other cells around to contribute
their cytokine products to the developing DC precursor.
Apart from the number of cytokines involved, the most
striking aspect of our study was our difficulty in demon-
strating any marked effect of GM-CSF on the development
of DC from the thymic precursors. This stands in complete
Figure 7. The expression of typical thymic DC surface markers on the
DC developing in culture of thymic low CD4 precursors. The precursors
(20,000) were grown for 4 d in 0.1 ml medium in 96-well, flat-bottomed
culture trays, in the presence of IL-1b, TNF-a, IL-3, IL-7, and SCF,
alone (left) or together with Flt3L and the mAb FGK45.5 reactive with
CD40 (right). The cultured were harvested, pooled, dissociated by EDTA
treatment, and then stained with mAb, generally in two fluorescent col-
ors. Full details are given in Materials and Methods. Dead or damaged
cells, z15% of the total, were excluded from analysis by propidium io-
dide staining and forward light scatter characteristics; otherwise, all cells
growing in the cultures are represented in fluorescence distribution pro-
files. The broken line gives the background staining, omitting the relevant
mAb. Each result is representative of two to five such analyses.
Figure 8. The expression of characteristic T cell, B cell, or myeloid cell
markers on the DC developing in culture of thymic low CD4 precursors.
Details are as in Fig. 7.2194 Dendritic Cell Development in Culture
contrast to the central role of this cytokine in most studies
of DC development in culture (2–4, 6–17). Our experi-
ments using anti–GM-CSF antibody, and using GM-CSF–
deficient mice, indicate that this is not due to endogenous
GM-CSF generation nor to a requirement for GM-CSF at
an earlier developmental stage than the low CD4 precur-
sor. Nor can it be entirely explained by a substitution of
IL-3 for GM-CSF as the cytokine signaling through the
GM-CSF receptor b chain, although GM-CSF and IL-3
are partially exchangeable in giving a twofold enhancement
of DC production. The thymic precursors and their thymic
DC progeny presumably have receptors for GM-CSF, be-
cause this cytokine when used alone does improve viability
in culture, and in the absence of IL-3 it can enhance DC
production; however, it is not essential in cell proliferation
or differentiation to DC. It is possible that the role of GM-
CSF in all other studies to date has been indirect, via its
cytokine inductive effects on cells other than the DC pre-
cursors in the heterogeneous precursor preparations. How-
ever, it seems more likely that this lack of effect of GM-
CSF is due to our outgrowth of a lymphoid-derived rather
than a myeloid-derived class of DC. It should be noted that
the evidence for a myeloid origin of DC comes from cul-
tures grown using GM-CSF, so this type of experiment
would selectively address the origin of only one type of
DC. It will now be important to determine what propor-
tion of DC found in various lymphoid organs are of mye-
loid precursor versus lymphoid precursor origin. It is of in-
terest that DC can also be produced from bone marrow
precursors using our cytokine mix lacking GM-CSF.
However we do not know the lineage origin of these DC.
The DC we develop in culture from the thymic low
CD4 precursors using the optimum complement of cyto-
kines appear similar to normal thymic DC in CD4 T cell
stimulatory function, and in most of the common DC cell
surface markers. However, there are some differences in
surface phenotype from normal thymic DC. Some markers
that are higher than on normal thymic DC may be a simple
consequence of growth in culture; thus CD11b (Mac-1),
although lower on freshly isolated normal thymic DC, may
be upregulated by overnight incubation in culture to levels
similar to those on the DC we generate in culture (D. Vre-
mec, unpublished data). Some markers that are missing may
indicate that the factors required for upregulation, present
in the normal thymus, are lacking in our cultures. Thus
we have already established that BP-1, normally expressed
on thymic DC and on the DC progeny of the low CD4
precursors if they develop in the thymus of an irradiated re-
cipient, is absent when the same precursors produce DC
progeny in the spleen (27). We assume, therefore, that our
cultures lack the thymus-specific induction factors required
for BP-1 expression. However, the absence of CD8a on
the DC we generate from the low CD4 precursors in cul-
ture is surprising and presents us with a paradox.
Most DC in the thymus, and a proportion of those in
spleen and LN, express CD8 as an aa homodimer (21, 26).
We have found in intravenous transfer studies that CD8a
serves as a marker of the DC progeny of the low CD4 pre-
cursor, in both the thymus and the spleen of irradiated re-
cipients (27). On this basis we suggested that normal
CD8a1 DC are lymphoid derived, whereas the CD82 DC
found in spleen and LN are myeloid derived. It now seems
CD8a is not an inevitable marker of lymphoid-derived
DC, raising the possibility that many of the CD82 DC
found in normal lymphoid tissue are also lymphoid de-
rived. In fact, in more recent studies (L. Wu, unpublished),
we have found the DC progeny found in LN after intrave-
nous transfer of thymic low CD4 precursors include CD82
as well as CD81 DC. CD8a expression may be induced by
some aspect of the environment common to both thymus
and spleen, less pronounced in LN, but not reproduced at
all in our cultures.
DC expanded in culture using GM-CSF show great prom-
ise as natural adjuvants for enhancing immune responses to
tumors and other antigens (for review see reference 36).
Our results indicate that the use of different combinations
of cytokines could allow the outgrowth of different types
of DC, originating from different precursor cells. Our
other studies indicate that some types of DC have an inhib-
itory or regulatory effect on T cell responses (28, 37). Ac-
cordingly, it will be important to reevaluate the immune-
stimulatory capacity of the DC produced when different
cytokine combinations are used, because it may be possible
to generate DC that inhibit rather than enhance an im-
mune response.
Figure 9. The stimulation of CD4 T cell proliferation by the DC de-
rived in culture from the thymic low CD4 precursors. The cultured DC were
harvested on day 4 from cultures of thymic low CD4 precursors grown in
the presence of the cytokines IL-1b, TNF-a, IL-3, IL-7, SCF, Flt3L, and
the mAb FGK45.5 reactive with CD40. These were compared with nor-
mal thymic DC extracted directly from the thymus and finally purified by
sorting based on CD11c expression. Purified CBA LN CD4 T cells
(20,000) were cultured for 3 d with various levels of the C57BL/6-derived
DC, and then the cultures were pulsed for 9 h with [3H]TdR. The cells
were collected onto glass-fiber filters, and proliferation was assessed by mea-
suring incorporated radioactivity using gas flow scintillation counting.
Full details are given in Materials and Methods. Results are the means 6
SEM of the pooled data from two experiments, each with five cultures
per point. Similar results but with somewhat lower counts were obtained
at days 2.5 and 3.5 of harvest. The background count with T cells alone
was 17 6 1 cpm, and the stimulation index was .300. The background
count with 2,000 fresh thymic DC alone was 77 6 22 cpm, and with
2,000 cultured DC alone was 109 6 14 cpm.2195 Saunders et al.
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